CAPR · Capricor Therapeutics, Inc.

$6.29 -0.55 (-7.97%) At close · Aug 21

Market Cap

$365.69M

58.14M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established	Last Amended	Capacity	Sold	Remaining	Runs Through	Source
2025-09-10	2025-12-05	$125,000,000	$77,500,000 as of 2026-03-31 / 2,682,307 shares as of 2026-03-31	—	—	10-Q , filed 2026-05-13
2021-06-21	—	$75,000,000	$75,000,000 as of 2024-10-01 / 9,228,383 shares as of 2024-10-01	—	2024-10-01 expired	10-Q , filed 2025-08-11

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2020-12-31	$0	—	—	10-K, filed 2021-03-15
2019-12-31	$193	—	—	10-K, filed 2021-03-15
2018-12-31	$0	—	—	10-K, filed 2020-03-27

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2019-12-31	$0 Δ	—	—	10-K, filed 2021-03-15
2019-09-30	$0 Δ	—	—	10-Q, filed 2020-11-13
2018-12-31	$0 Δ	—	—	10-K, filed 2020-03-27
2018-09-30	$0 Δ	—	—	10-Q, filed 2019-11-08

Key facts CIK 1133869 CUSIP 14070B309 13F (30d) 168 filings 163 filers Visit website Investor relations